December 12, 2024 02:07 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Donald Trump vows to eliminate birthright citizenship after taking charge | No alliance with Congress in Delhi polls: AAP chief Arvind Kejriwal | Bengaluru techie's suicide: Atul Subhash's wife and her family booked | Bengaluru techie's suicide: Atul Subhash's wife and her family booked | INDIA bloc to knock on Supreme Court's doors over alleged EVM manipulation during Maharashtra polls | 'Babri Masjid should be rebuilt in Bengal's Murshidabad': TMC MLA Humayun Kabir sparks row | Rajnath Singh calls on Russian Prez Vladimir Putin in Moscow, discusses bilateral defence cooperation | Police to investigate conspiracy angle in Mumbai bus accident that killed 7 | Mamata Banerjee should lead INDIA bloc: Lalu Prasad Yadav | Opposition moves no-confidence motion against VP Jagdeep Dhankar in RS
Booster shot offers nine-fold increase in COVID-19 antibodies: Johnson & Johnson

Booster shot offers nine-fold increase in COVID-19 antibodies: Johnson & Johnson

Aug 26, 2021, at 12:28 am

Washington/UNI/Sputnik: US pharmaceutical giant Johnson & Johnson said on Wednesday that a study showed a nine-fold increase in COVID-19 antibodies in participants who took a booster dose of its single-shot COVID-19 vaccine.

Johnson & Johnson seeks approval for trial of COVID vaccine on adolescents in India

Johnson & Johnson seeks approval for trial of COVID vaccine on adolescents in India

Aug 21, 2021, at 01:49 am

New Delhi/IBNS: US pharma major Johnson & Johnson (J&J) has written to Central Drugs Standard Control Organisation's (CDSCO) seeking approval for the clinical trial of its COVID-19 single-shot Janssen vaccine among children aged 12 to 17 years.